Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Increased Xanthine Oxidoreductase Activity in Patients With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension

CHEST Pulmonary(2025)10.1016/j.chpulm.2025.100212Source: DataRank Database

Increased Xanthine Oxidoreductase Activity in Patients With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension is a research paper published in CHEST Pulmonary (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.00)OA: goldTopics (13)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Tijana Tuhy ORCID,Adrianne Woods,Laura K. Hummers ORCID,Ami A. Shah ORCID,Paul M. Hassoun ORCID

Live enrichment

PubMed:41924336 OpenAlex:https://openalex.org/W4414111115

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Grant: P30 AR070254

National Heart, Lung, and Blood Institute

Grant: K24 AR080217

National Heart, Lung, and Blood Institute

Grant: K23HL153781

National Heart, Lung, and Blood Institute

Grant: R03HL176624

NHLBI NIH HHS

Grant: T32 HL007534

FWCI

0.00

Citation Percentile

0.2%

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.chpulm.2025.100212

publisherhttps://doi.org/10.1016/j.chpulm.2025.100212

publisherhttps://api.elsevier.com/content/article/PII:S2949789225000790?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2949789225000790?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41924336

Fields of Study

Gout, Hyperuricemia, Uric AcidPulmonary Hypertension Research and TreatmentsSystemic Sclerosis and Related Diseases

Keywords

Pulmonary hypertensionHyperuricemiaUric acidCohortSystemic sclerodermaScleroderma (fungus)Endothelial dysfunctionXanthine oxidasepulmonary arterial hypertensionscleroderma